| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_CCDC66_0006400 | Exon-Exon | chr3:56600978-56628056 | chr3:56566950-56594028 | 336 nt | 0.4494 |
| hsa_CCDC66_0006500 | Exon-Exon | chr3:56600978-56647778 | chr3:56566950-56613750 | 284 nt | 0.4366 |
| hsa_CCDC66_0006600 | Exon-Exon | chr3:56600978-56649300 | chr3:56566950-56615272 | 1071 nt | 0.4108 |
| hsa_CCDC66_0006700 | Exon-Exon | chr3:56600978-56651489 | chr3:56566950-56617461 | 104 nt | 0.4327 |
| hsa_CCDC66_0006800 | Intron-Exon | chr3:56601354-56603898 | chr3:56567326-56569870 | 2545 nt | 0.4130 |
| hsa_CCDC66_0007000 | Exon-Exon | chr3:56603341-56603665 | chr3:56569313-56569637 | 325 nt | 0.4985 |
| hsa_CCDC66_0007100 | Intron-Exon | chr3:56603341-56605330 | chr3:56569313-56571302 | 447 nt | 0.4430 |
| hsa_CCDC66_0006900 | Intron-Exon-Intron | chr3:56603341-56605552 | chr3:56569313-56571524 | 2212 nt | 0.3983 |
| hsa_CCDC66_0007200 | Exon-Exon | chr3:56603422-56603665 | chr3:56569394-56569637 | 244 nt | 0.4918 |
| hsa_CCDC66_0007300 | Intron-Exon-Intron | chr3:56605172-56627769 | chr3:56571144-56593741 | 634 nt | 0.3833 |
A study in human lung adenocarcinoma cells demonstrated that the circCCDC66 increases epithelial-mesenchymal transition and drug resistance [Huang et al. DOI:10.3390/cells11091381].